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Peptides present in phages were selected using phage display technology and immunoassays to find 
out the antigenic mimetics of immunodominant epitopes of bovine leukosis virus (BLV). The use of 
antigenic mimetics may result in the enhancement of the sensitivity and specificity of the serologic 
diagnosis of enzootic bovine leukosis (EBL), contributing directly to disease control. The selections 
enabled the choice of clones which can be used as potential antigens in the diagnoses of diseases. The 
synthetic peptide produced from the selected sequences may be considered as an alternative for 
antigens in the serologic diagnosis of enzootic bovine leukosis.  
 





The bovine leukosis virus (BLV) is a member of the 
genus Deltaretrovirus and an etiologic agent of enzootic 
bovine leukosis (EBL). The EBL shows a worldwide 
distribution and infects more frequently, the dairy cattle 
(Modena et al., 1984; Castro et al., 1992; Camargos et 
al., 2002). The economic damages caused by BLV 
infection include restrictions on the trading of the animal 
or its products such as semen and embryos between 
countries (Burny et al., 1980; Gutiérrez et al., 2009). 
Other economic damages include bovine deaths due to 
lymphosarcoma, carcass rejection at the slaughterhouse, 
and productive and reproductive decrease in infected 
animals (Camargos, 2005). BLV infection also decreases 
milk production and causes other losses to farmers (Da 
et al., 1993). 
As there are no protective vaccines against the virus, 
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through diagnosis, segregation and slaughtering of the 
bovine carriers. For this reason, the sensitivity of the 
diagnostic technique utilized is regarded as a critical 
factor to prevent the spread of the disease in the flocks 
(Trono et al., 2001). 
Like other retroviruses, the BLV presents envelope 
glycoprotein gp51 (env) and core viral p24 (gag) as 
immunodominant proteins in vivo (Miller et al., 1981; 
Portetelle et al., 1989; Callebaut et al., 1993; Gatei et al., 
1993; Willems et al., 1995; Doménech et al., 1997). The 
proteins gp51 and p24 are frequently used in diagnostic 
tests for the detection of specific BLV virus antibodies 
(Miller et al., 1981; Kittelberger et al., 1999). The most 
utilized tests for EBL diagnosis are agar gel 
immunodiffusion (AGID) and enzyme-linked 
immunosorbent assay (ELISA), but several factors may 
contribute to the inconsistency of results such that a need 
arises for the results to be confirmed by other more 
sensitive and specific techniques (Van Der Maaten, 1974; 
Portetelle et al., 1989; Reichel et al., 1998; Soutullo et al., 
2001; Trono et al., 2001; De Giuseppe et al., 2004; 
Leroux et al., 2004; Paré and Simard, 2004; Alvarez et 
al., 2007; Lim et al., 2009). Techniques such as western 





developed and used as complementary or confirmatory 
diagnostic tools for EBL and other retroviruses (Payne et  
al., 1989; Kim and Casey, 1992; Langemeier et al., 1996; 
Johnson et al., 1998; Reichel et al., 1998; Kittelberger et 
al., 1999; Llames et al., 2000; Trono et al., 2001; Choi et 
al., 2002; Alvarez et al., 2007; More et al., 2008). 
Even though many assays have been performed to 
improve antigen production, the traditional cell culture 
method of production which involves the use of strain 
FLK/BLV is still the mostly used method in antigen 
production for commercial diagnostic kits (Van der 
Maaten et al., 1974; Beier et al., 2004; Lim et al., 2009). 
The cell strain FLK used in BLV antigen production is 
also known for being infected with bovine diarrhea virus 
(Bolin et al., 1994; Dees et al., 1994; Beier et al., 2004; 
Lim et al., 2009) and this contamination may result in 
further problems with diagnoses related to the specificity 
of the reactions (Beier et al., 2004). Other problems 
common with the antigen productions techniques which 
utilize cell cultures is that the growth protocols usually 
includes the addition of bovine fetal serum. This serum 
contributes to the components that may cause unspecific 
reactions. Besides these factors, the presence of cell 
proteins that are not eliminated or that are co-purified 
during the obtention of BLV proteins may interfere with 
the viral proteins (Llames et al., 2000), thus, producing 
mistaken results in EBL diagnosis.  
Advances in vaccines and diagnostic tests develop-
ment require a deeper understanding of pathogen 
antigenic structures and immunogenic proteins. The 
synthetic peptides have been utilized for mapping the 
antigenic sites in several viral systems (Neurath et al., 
1990; Callebaut et al., 1991; Ball et al., 1992), presenting 
a wide potential when utilized as antigens in diagnostic 
techniques and as efficient vaccine components in the 
induction of the immunologic memory (Ball et al., 1992; 
Kabeya et al., 1996; Soutullo et al., 2001, 2005). 
Peptides selected by a phage display-technology such as 
antigenic mimetic of natural epitopes may be used to 
immunize animals. Some of them are capable of inducing 
new antibodies that present cross-reaction with the 
natural epitopes which are considered as mimetic 
immunogenic (Cardoso et al., 2009). In order to avoid the 
problems presented by use cell culture in the production 
of antigens from, antigenic mimetics and immunogenic 
capabilities are utilized as the foundations which help to 
find epitopes that are used in the development of 
vaccines and diagnostic techniques for many diseases 
(Folgori et al., 1994; Pasqualini et al., 1995; Sioud et al., 
1996).  
In this study, the peptides present in phages were 
selected from phage display libraries and from immu-
noassays. These peptides were regarded as antigenic 
mimetics of the immunogenic epitopes of BLV proteins, 
having the potential for being used as antigens and in 
synthetic peptide production for the development of 
diagnostic techniques for EBL.  






Purification of IgG from bovine sera 
 
Bovine sera samples were tested for BLV infection in the 
Retroviruses Laboratory of Veterinary School, Universidade Federal 
de Minas Gerais (UFMG), using agar gel immunodiffusion (AGID) 
test as recommended by Miller and Van der Maaten (1977) with the 
antigen gp51 produced in FLK cells. In order to obtain total IgG 
from a positive pool sera for EBL from 20 animals and total IgG 
from a negative pool sera from 20 different animals, a HP column 
Hitrap Protein G in ÄKTA system was used following the 
manufacturer’s instructions (GE Healthcare®). The total IgG 
obtained from 3 ml of each pool were neutralized after the elution of 
the column with buffer 1 M Tris-HCl of pH 8.0, lyophilized, frozen 
and diluted in deionized\sterilized water.  
The concentrations of purified IgG and gp51 protein were 
estimated by spectrophotometry at 280 nm and by using the 
Bradford method (Bradford, 1976). The samples were submitted to 
electrophoresis in 16% sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) and stained with Coomassie-blue R-
250. The molecular weight marker Bench Mark Protein Ladder 
(Invitrogen) was applied to the gel for comparison. 
 
 
Biological selection (biopanning) 
 
The Ph.D. -12TM library - New England BioLabs® was used for the 
selection of peptide sequences bound to purified IgG from BLV-
positive animal sera. This library contains random and linear 
peptides which consist of 12 amino acids and presents about 2.7 × 
109 possible sequences. 
The positive purified IgG were utilized as target for peptide 
selection. The wells of microtitration plate (MaxiSorpTM - Nunc) 
were adsorbed using 150 µl of IgG positive for BLV at the 
concentration of 100 µg/ml in 0.1 M NaHCO3, pH 8.6. Phages at the 
concentration of 4.0 × 1010 of the original library were diluted in 90 
µl of Tris-buffered saline Tween-20 (TBST) solution and added to 
the wells adsorbed with the targets (total positive IgG). Three 
selection cycles were performed for the enrichment of the phages 
containing the linking peptides. From the 2nd cycle, the washing 
buffer stringency increased from 0.1 to 0.5% with Tween-20 in all 
the washings. In the 3rd cycle, 15 washings were carried out, and 
after this step, the phages containing the linking peptides were 
withdrawn. 
The procedures for biopanning, amplification, precipitation and 
titration of the phages were performed according to the instructions 





For the sequencing reaction, 500 ng of template DNA (DNA of each 
phage), 5 pmol of -96 gIII primer (5’-OH CCC TCATAG TTA GCG 
TAA CG-3’ - Biolabs) and Premix (DYEnamic ET Dye Terminator 
Cycle Kit – Amersham Biosciences) were used. The reaction was 
carried out in a plate thermocycler (MasterCycler – Eppendorf).  
The reading of the sequencing was carried out in a MegaBace 1000 
(Amersham Biosciences) automatic sequencer. The DNA 
sequences obtained from the automatic sequencer were processed 
by the appropriate software equipment (Sequence Analyzer, Base 
Caller, Cimarron 3.12, Phred 15). 
 
 
Translation and analysis of sequences  
 
From the DNA sequences, analysis of deduction in silico were 
performed for the peptide sequences using the software DNA2PRO  




(available at https://relic.bio.anl.gov/programs.aspx). The software 
AAFREQ (https://relic.bio.anl.gov/aafreqs.aspx) was used for 
calculating the frequency and diversity of amino acids inside the 
population of selected peptides. The search for similarities between 
the peptides selected was accomplished using the software Clustal 
W (version 18.1 available at www.ebi.ac.uk/clustalW/), through 





The phage M13KE (New England BioLabs®) was used in the 
immunoassays as negative control for the reactions. This phage 
does not present peptides fused to viral capsid. According to the 
manufacturer’s information, this clone may be useful as control or in 
titration of phage stocks. The procedures of amplification, 
precipitation and titration of the wild phage were the same as those 





High affinity plates (MaxiSorpTM - Nunc) were adsorbed with 
positive and negative purified IgG. 44 ELISA plate wells were 
adsorbed with 1 µg of positive IgG diluted in a bicarbonate buffer 
(0.1 M NaHCO3, pH 8.6) and the other 44 wells of the same plate 
were adsorbed with 1 µg of negative IgG. In each half of the 
microplate, four wells were used as controls without IgG adsorption. 
The plate was incubated for 18 h at 4°C under agitation, washed 
twice in 0.05% PBST and blocked with PBS solution with 5% 
skimmed powdered milk for 1 h at room temperature. After that, the 
plates were washed three times. 
The phage samples were precipitated with polyethylene glycol 
(PEG)/NaCl and with concentrations estimated by UV absorbance 
spectrophotometry at the wave lengths of 269 and 320 nm, they 
were diluted to the concentration of 1x1011 phages in the PBS 
solution with 1% skimmed powdered milk. Each phage sample was 
added in duplicate to the wells with positive and negative IgG 
adsorbed and incubated for at least 1 h at 37°C. The wild phage 
(negative control) was added to the adsorbed and non-adsorbed 
wells with the IgG according to the layout of plates. 
The plates were washed six times with 0.05% phosphate 
buffered saline with Tween 20 (PBST) and incubated for 1 h at 
37°C with anti-M13-peroxidase-conjugated (1:5000, Sigma) in PBS 
solution with 1% skimmed powdered milk. By the end of the 
incubation, the plates were washed six times with 0.1% PBST 
solution and the reaction was initiated by the addition of 0.03% 
H2O2 and o-phenylendiamin (OPD) 1 mg/mL in 0.1 M citrate-
phosphate with pH 5.0. The reaction was interrupted by adding 
sulphuric acid (2 N) and the optical density (OD) was determined by 
plate spectrophotometry (Titertek Multiskan Plus, Flow 
Laboratories, USA) at 490 nm. 
The cut-off value was calculated based on the OD obtained for 
the wild phage (cut-off = wild phage average value + 2X the 
standard deviation value for wild phage). The ELISA index was 
calculated by taking the OD average of the duplicates divided by 
the cut-off value. Values greater than one were considered positive. 
In order to verify the difference between the ELISA indexes 
obtained from the reactivity of positive and negative IgG clones, the 
paired t-test was performed with the software STATA 10.0. 
 
 
Dot blot (IgG) 
 
The Dot blot was performed to verify the reactivity of the phages 
with positive and negative IgG. Nitrocellulose membranes (0.2 µm, 
Amersham Pharmacia) were sensitized with each phage in the 





also sensitized. After the sensitization, the membranes were 
blocked with PBS with 5% skimmed powdered milk for 1 h under 
agitation at room temperature and washed once in 0.05% Tris-
buffered saline Tween-20 (TBST) . 
Positive and negative IgG were used as primary antibodies in the 
concentration of 400 µg diluted in block solution and incubated 
within the membranes for 1 h under agitation and at room 
temperature. After five washings with Tris-buffered saline Tween-20 
(TBST) 0.05%, the reaction was initiated by adding 3,3'-diamino-
benzidine (DAB) (Sigma Chemical) for visual reading and 
interrupted with deionized H2O. 
 
 
Western blot (IgG and sera) 
 
Western blot (WB) was performed to confirm if the peptides fused to 
protein III of the selected clones were immunoreactive with positive 
IgG and antibodies from positive sera for BLV, and capable of 
differentiating the positive and negative samples.  
For the WB assays, an electrophoresis in 16% SDS-PAGE was 
performed with each selected phage (1x1012 pfu), wild phage 
(negative control, 1x1012 pfu), and gp51 (10 µg). The samples were 
electrotransferred for 2 h in 280 mA at 4°C to nitrocellulose 
membranes (0.2 µm, Amersham Pharmacia) which were blocked 
by TBS solution with 5% skimmed powdered milk for 1 h under 
agitation at room temperature. After a wash with 0.05% Tris-
buffered saline Tween-20 (TBST)  solution (50 mM Tris-HCl pH 7.5, 
150 mM NaCl and 0.05% Tween 20), positive and negative IgG 
(400 µg), and positive and negative sera samples for BLV (1:500) 
were diluted in blocking solution and incubated in the membranes 
for 1 h under agitation at room temperature. The membranes were 
washed three times in 0.05% Tris-buffered saline Tween-20 (TBST) 
solution. Secondary antibody anti-IgG bovine conjugated to 
peroxidase (1:5000, Sigma) which was diluted in blocking solution 
was added to each membrane. They were incubated for 1 h under 
agitation at room temperature, and afterwards, washed three times 
in 0.05% Tris-buffered saline Tween-20 (TBST) solution. The 
reaction was initiated with DAB (Sigma) for visual reading and 





Only clones non-reactive with negative IgG and clones reactive with 
the positive IgG were selected. The immunoreactivity of the phages 
selected using positive and negative sera samples for BLV infection 
was tested by ELISA. The bovine sera samples had previously 
been tested by AGID according to the protocol of Miller and Van der 
Maaten (1977). 
The samples of the selected phages and of the wild phage were 
diluted to the concentration of 1×1011 in 0.1 M NaHCO3 with a pH of 
8.6 for the adsorption in the wells of ELISA plates (MaxiSorpTM - 
Nunc). After adsorption (18 h at 4°C), the plates were washed twice 
in 0.05% PBST and blocked with PBS with 5% skimmed powdered 
milk for 1 h. After three washings, 20 positive sera samples and 20 
negative sera samples were diluted to 1:100 in PBS solution with 
1% skimmed powdered milk and added in duplicates to the wells. 
The incubation was for 1 h at room temperature. Wells that did not 
receive sera samples were considered as blank reaction. Six 
washings were carried out. The secondary antibodies anti-IgG 
bovine conjugated to peroxidase (1:5000, Sigma) which were 
diluted in PBS solution with 1% skimmed powdered milk were 
incubated in the wells for 1 h at room temperature. The plate was 
washed six times and the reaction was initiated as described for 
Phage-ELISA with IgG. 
The cut-off value was calculated based on the average values of 
OD from the wild phage with positive and negative sera and the 
values of all the phages tested with all the negative  sera  +  2X  the  






Figure 1. Electrophoresis SDS-PAGE (16%) of the positive and negative samples. M, Molecular weight marker; + pool, 
positive pool sera for bovine enzootic leukosis (EBL) from 20 animals; - pool, negative pool sera for EBL from 20 animals; + 
IgG, positive IgG purified from positive pool sera; - IgG, negative IgG purified from negative pool sera; - sera, sera from 





standard deviation of the same values. From the cut-off, the 
positive and negative ELISA indexes were calculated thus for each 
phage sample tested: (i) positive ELISA index for each phage = OD 
average value obtained with all positive sera/cut-off; (ii) negative 
ELISA index for each phage = OD average value obtained with all 
the negative sera/cut-off. The ratio of positive and negative ELISA 
indexes (EI+:EI-) for each sample was calculated. Phages that 
presented the highest EI+:EI- were selected. 
 
 
Dot blot (sera) 
 
Dot blot was performed to verify the immunoreactivity of the phages 
selected with positive and negative sera for BLV infection. Twenty 
positive sera samples and 20 negative sera samples were tested at 





The peptides selected by immunoassays were analyzed using 
bioinformatics tools. The search for the similarities between the 
sequences was performed via the software Clustal W version 18.1 
(www.ebi.ac.uk/clustalW/). The sequences of the selected peptides 
were analyzed to determine their homology with the sequences of 
BLV proteins stored in the “GENEBANK” through the software 
Basic Local Alignment Search Tool (BLAST) (http://www.ncbi. 
nlm.nih.gov/BLAST/). To find the maximum similarity among all the 
selected peptides in the immunoassay and the BLV proteins of 
interest as revealed by Blast, the software MATCH available in the 
site http://relicbio.anl.gov/match.aspx/ was used.  
 
 




The system of multiple mimetic peptides (“multiple antigens 
peptides”) from the selected sequences was utilized. The synthetic 
peptide VLB-Ph was planned with repetitions in tandem, presenting 
the same   spacer   (GGGS)   and   had   C-terminal   amide   for   
the stabilization of peptide structure. The peptide was synthesized 
by Genscript (www.genscript.com). 
The VLB-Ph presents 60 amino acid residues with molecular weight 
6117.1, isoelectric point (IP) 12.4 and a positive charge in pH 7.0 of 
+ 4.4. 
The peptide was diluted in sterilized/deionized water and its 
concentration was determined by spectrophotometry at 280 nm via 
the method of Bradford (1976). In order to verify the reactivity of the 






The 96-wells’ high affinity plates (MaxiSorpTM - Nunc) were 
adsorbed with 1 µg of the diluted peptide in bicarbonate buffer (0.1 
M NaHCO3, pH 8.6) for 18 h at 4°C. After the adsorption period, the 
plates were washed and blocked as previously described.  
30 positive sera samples for BLV infection and 30 negative sera 
samples previously tested by AGID according to the protocol of 
Miller and Van der Maaten (1977) were diluted 1:100 in PBS 
solution with 1% skimmed powdered milk and added in duplicates 
to the wells. After 1 h incubation at room temperature and six 
washings, secondary antibody anti- IgG bovine conjugated to 
peroxidase (1:5000, Sigma) which was diluted in PBS solution with 
1% skimmed powdered milk was incubated in the wells for 1 hour at 
room temperature. The plate was washed six times and the reaction 
was initiated as previously described. The analysis of the results 








The IgG purification process from a pool of bovine sera 
presented efficiency and had an approximate yield of 7 
µg/µl. Figure 1 presents the electrophoretical patterns of 
the   purified   IgG   with   respect   to  the  sera  pool  and  











molecular weight marker (M). The presence of a band of 
about 190 KDa in the sera pool samples as well as on the 
purified IgG corresponding to the approximated molecular 





All the eluates containing amplified and non-amplified 
phages obtained by biopanning were titrated to estimate 
the quantity of phages selected in the three cycles using 
the Ph.D.-12TM library. The titers of entrance of phage in 
the selection cycles were greater than the output titers 
which increased gradually from the 1st to the 3rd selection 
cycles. According to the reading of the sequencing 
reaction, 44 sequences were obtained from the selection 
done through Ph.D.-12TM library and were later 
translated by the software DNA2PRO. All the sequences 
were different in comparison to each other.  
According to the results obtained by the software 
AAFREQ, the most frequent amino acids were alanine, 
histidine, proline, threonine and tryptophan, and the 
search for similarities between the sequences performed 
using the software Clustal W version 18.1 revealed some 
common motifs between the selected peptides which 
include AHKW, AhxW, HKW, HxW, FAPT and WAPT. 
 
 
The initial selection of the phages by immunoassays 




The initial selection of the phages by immunoassays  was 
carried out using ELISA. The aim was to select the 
phages reactive with positive IgG and those which are 
non-reactive with negative IgG. 
From the 44 phages obtained after sequence analysis, 
just 23 were reactive with positive IgG and non-reactive 
to negative IgG. The only phages which were reactive 
with positive IgG included A1, A3, A4, A9, C5, C7, D4, 
D5, D10, E6, F1, F5, F8, F10, G5, G6, G10, H1, H6, H7, 
H8, H10 and H11. The reactivity index of positive IgG 
varied a lot among the selected phages (Figure 2). 
In order to verify the difference between the ELISA 
indexes obtained, the paired t-test was performed by the 
software STATA 10.0. The value p< 0.001 shows a 
significant reactivity difference of the phages with positive 





The 23 selected phages, wild phage and gp51 protein 
were electro-transferred to nitrocellulose membranes 
after SDS-PAGE 16%. No reactivity of the phage 
samples and gp51 with the negative IgG was observed. 
In addition, only the phage samples G10 and H1, and 
wild phage (negative control) did not react with the 
positive IgG, other phage samples and gp51 reacted with 





According to the results of Dot blot (data not shown), the 
phages A9, C7, G5, D4, F5, H11, D5, H6, D10 and F10 
presented the best results in respect of  the  difference  of  








































Figure 3. Phages selected by ELISA from the analysis of the reactivity of 20 positive sera and 20 negative sera for EBL. ELISA, 




reactivity with the positive and negative IgG. The wild 
phage did not react in the assay, and the gp51 did not 




Reactivity of protein gp51 with purified 
immunoglobulins and sera samples  
 
The gp51 did not present reactivity in the ELISA experi-
ments performed using positive and negative IgG or the 
sera samples (Figure 3). Through an electrophoresis 
SDS-PAGE, it was possible to evaluate the quality of the 
sample of the protein gp51 utilized in the tests (data not 
shown). The protein presents mass with an approximate 
value of 60 KDa (Llames et al., 2000).  
 
 
The analysis of the reactivity of the phages with sera 
samples 
 
The 23 phages selected with purified IgG were also 
evaluated in the immunoassays with positive and 
negative sera for BLV. 
 
 
Phage ELISA  
 
The selected phage samples, wild phage and gp51 were 
adsorbed in the ELISA plate and incubated with sera 
samples. Positive ELISA indexes (EI +) and negative 
ELISA indexes (EI -) were calculated and the greater 
values  were  used  to  determined  the  phage  samples 
(antigens) with greater ability to differentiate the positive 
sera and the negative sera. The phages that presented 
the best results were selected and they include A3, A4, 
A9, D4, D10, F5, F10, G5 and H11 (Figure 4).  
 
 
Dot blot  
 
According to the results obtained by Dot blot, the phages 
that differentiated sharply the positive (coloured dots) and 
negative sera samples (uncoloured dots) were A3, A4, 
A9, D4, D10, F5, F10, G5 and H11 (Figure 4), thus, 
confirming the ELISA results. The wild phage did not 
react with the sera, and gp51 did not diferentiate the 
samples (data not shown). 
 
 
Western blot  
 
All the nine phage samples presented the reactivity of pIII 
protein (~ 42 KDa) with positive sera (visible coloured 
bands) and non-reactivity with negative sera (no visible 
coloured bands) (Figure 5). The wild phage did not 
present any reaction to the sera, and gp51 did not 
diferentiate between positive and negative sera (data not 
shown). According to the results obtained from the 
immunoassays with purified IgG and with field sera 
samples, the phages with sequences that presented 
better antigenic features which differentiated the positive 
and negative sera were: (i) A3 (ahkwdiplstsg), (ii) A4 
(ahkweavqppmt), (iii) A9 (ipastidllppl), (iv) D4 
(hkpppqtrlmha), (v) D10 (ghkwspivqpsp), (vi) F5 
(lprsaidwlapv),   (vii)    F10    (wyppmhifapts),    (viii)    G5  





Positive sera samples 
Negative sera samples 
 
 
Figure 4. Dot blot test of the reactivity of selected phages with the positive and negative sera 
samples for EBL. The superior part of the black arrow indicates membranes incubated with 
positive sera samples, while the inferior part of the black arrow indicates membranes 






Positive sera sample 
Negative sera sample 
 
 
Figure 5. Western blot assay for the reactivity test using phages as antigens in positive and negative sera samples for EBL. M, 
molecular weight marker; superior membrane, positive sera incubation; inferior membrane, negative sera incubation. 






Figure 6. Reactivity analysis of 30 positive sera samples and 30 
negative sera samples for BLV infection with the synthetic peptide 
VLB-Ph in ELISA via the software Prisma 5.0. BLV, Bovine leukosis 









The similarity between the sequences were analyzed by 
multiple alignments with the software Clustal W version 
18.1 which identified the common motifs AHKW, HKW or 
HKx, FAPT and PPM. The selected peptide sequences 
were also analyzed for homology with BLV proteins 
sequences deposited in the “GENEBANK” through the 
software BLAST. According to these results, the 
sequences of the peptides show similarity with the BLV 
sequences G4 (ABE28439.1), tax (ACR15161.1), gp51 
(CAR64532.1), p34 (AAC82590.1), gp30 (AAP32011.1), 
gp60 (NP777385.2), p24 (AAA42784.1), protease 
(AAB50411.1), integrase (ACR15158.1), reverse trans-
criptase (ACR15158.1), rex (ABE28498.1), env 
(ACR15160.1) and pol (AAA42785.1). The software 
MATCH was used to calculate the maximum point of 
similarity between some of the selected peptides and the 
BLV proteins of interest from Blast search. The peptides 
from phages D10, G5 and A9 showed maximum 
similarities with p24, the main BLV capsid protein 
encoded by the gene gag, while the peptide from phage 
D4 showed maximum similarity with glycoprotein gp51 of 
the viral envelope encoded by gene env. 
 
 
Synthesis of the peptide containing epitopes 
mimetics of the bovine leukosis virus (BLV) 
 
According to the results obtained from the immunoassays 
and   bioinformatics   analysis,   the  peptide    sequences  
displayed by phages D4 and G5 were selected for the 
development of a synthetic peptide.  
The synthetic peptide was designed with two repeti-
tions of each sequence intercalating between the linker -
GGGS- and C-terminal amidation for the stabilization of 
the peptide structure. The peptide called VLB-Ph was 
produced, presenting the sequences hkpppqtrlmha and 
nmlqiappfpas which correspond to the sequences of 







The reactivity of the synthetic peptide VLB-Ph in 
ELISA with sera samples  
 
The statistics which invovled the use of the software 
Prisma 5.0 for t-test with the values of the ODs indicated 
a difference among the results for positive and negative 
sera samples with the peptide VLB-Ph in ELISA. The p 
value was 0.0114, showing a significant difference 





Phage display techniques which were utilized in the 
discovery of epitopes are important for the development 
of diagnostic platforms and vaccines (Smith and 
Petrenko, 1997; Ziegler et al., 1998; Casey et al., 2009). 
This methodology enables the identification of new 
antigens with no previous information on the properties of  




the antibodies, avoiding the preparation and charac-
terization of the individual monoclonal antibodies 
(Parmley and Smith, 1988, 1989). 
In this study, selected peptides were regarded as 
epitopes mimicking the proteins of bovine leukosis virus 
(BLV). The peptides were obtained by immunologic 
selection from library Ph.D.-12TM presented in phages 
against purified immunoglobulins of a pool of sera from 
animals naturally infected by BLV. The isolation of 
peptides that present similarities with the BLV proteins 
was carried out through repeated selection cycles of the 
peptides by immunologic affinity to the biologic target 
(positive IgG). So, the selection cycles and amplification 
tend to generate specific peptides recognized by the 
antibodies showing higher titers, producing specific sub-
populations of clones with affinity for IgG (Parmley and 
Smith, 1988, 1989). After biologic selection (biopanning), 
the phages clones were characterized and validated 
through the usage of specific criteria. Phage titration in 
the beginning and at the end of the selection cycles were 
carried out to obtain the enrichment of the eluates during 
the selective process. Presumably, the phages with 
higher affinity to the positive IgG remained bound and 
phages with low affinity were removed in the washing 
processes. The output titers gradually increased from the 
1st to the 3rd round, indicating the enrichment of positive 
clones and that the selections were directed towards the 
target (Ziegler et al., 1998; Kirsch et al., 2008; Leong et 
al., 2008). 
Based on the results of the selection done through the 
library Ph.D.-12TM, 44 different sequences were 
obtained with high frequencies of the amino acids 
alanine, histidine, proline and tryptophan, and common 
motifs between the selected peptides AHKW, AhxW, 
HKW, HxW, FAPT and WAPT, suggesting that these are 
the main participants in the interactions with target for 
biological selection. The initial selection of the phages 
through immunoassays was performed with the aim of 
identifying phages that react only with positive IgG and 
not with negative IgG. From the 44 peptide sequences 
obtained, only 23 were selected based on the results of 
ELISA, Dot blot and Western blot with purified IgG. 
Based on the large ratios of positive and negative 
indexes (EI+:EI-) in both ELISA and Dot blot serum 
assays, nine phages were selected because of their 
potential to differentiate between positive and negative 
sera samples. The results of the assays using the wild 
phage (negative control) and the results obtained from 
the Western blot proved that only peptides fused to 
protein III were specifically recognized by purified IgG 
and antibodies from sera samples. 
Based on the similarity analysis, these peptide 
sequences were found to be similar to protein p24 and 
glycoproteins gp51 and gp30 which show immune-
dominant epitopes as well as important proteins such as 
Tax, Rex and G4 which are related to the regulation of 





development of the infection (Burny et al., 1980; Miller et 
al., 1981; Walker et al., 1987; Willems et al., 1993, 1995). 
The peptides from phages D10, G5 and A9 presented 
great similarities with the protein p24 which is considered 
as the main protein of the BLV capsid (Miller et al., 1981), 
while the peptide from phage D4 presented a great 
similarity with the glycoprotein gp51 of the viral envelope. 
These two proteins are considered the most immune-
genic during BLV infection since many researchers have 
shown that the infected bovines developed a primary 
response to specific antibodies directed to the envelope 
glycoprotein gp51 and the core viral p24 protein 
(Deshayes et al., 1980; Portetelle et al., 1980; Walker et 
al., 1987). Using bioinformatics analysis, common motifs 
AHKW, HKW or HKx, FAPT and PPM were found in the 
nine selected peptides, indicating the importance of 
certain amino acids in distinghuishing between peptides 
and IgG (Cortese et al., 1995) as they potentially mimic 
the BLV protein epitopes.  
The sequences of the nine peptides selected showed 
similarities with various BLV proteins and played 
important regulatory, structural and immunodominant 
roles during the infection. Also, based on the results of 
the study, the phage display technique may be con-
sidered as a major tool to obtain a database of epitopes 
selected by immunologic interaction with antibodies that 
recognize the BLV proteins, but this technique needs to 
be verfied by different techniques. 
The immunoreactivity of the antigenic protein gp51 
which is produced in FLK cells was evaluated in the 
assays with purified IgG and with sera samples. In the 
ELISA tests, the protein gp51 did not show reactivity with 
the positive or negative IgG, but presented an almost 
insignificant reactivity with the sera samples. Due to this, 
it was not possible to use gp51 as a control or a 
competitor in phage ELISA assays. In the Western blot 
and Dot blot, the gp51 showed reactivity, but it did not 
differentiate positive and negative samples. The lack of 
reactivity of gp51 may be related to the absence of 
standardization of this kind of antigenic material to the 
techniques utilized since this antigen is prepared for 
AGID. Considering the low differentiation ability of gp51 
in the immunoassays, these mimetic peptides are 
potentially much better antigens for EBL diagnostics. 
With the immunoassay results and similarities found 
between the peptide sequences obtained from the 
selection with the library Ph.D.-12TM and the BLV 
immunodominant proteins, one can consider the selected 
nine peptides as mimetics of immunodominant epitopes 
of the virus. The mimetic antigens may work as specific 
probes for antibodies in the diagnoses of diseases in the 
same way that viral proteins are used in tests for 
illnesses caused by retroviruses. Moreover, they enable 
the emphasis on a specific recognition, excluding signals 
not related to the disease diagnosis and avoiding cross-
reactions (Smith and Petrenko, 1997). 





were utilized as criteria for selecting peptide sequences 
that constitute the synthetic peptide VLB-Ph, and ELISA 
tests performed with the VLB-Ph showed significant 
differences between positive and negative sera samples, 
although a great number of the samples need to be 
evaluated before the standardization of the use of this 
peptide in serologic tests. 
This study demonstrated that mimetic antigen selection 
of the BLV proteins from the phage display libraries may 
represent an important tool to define epitopes that are 
recognized by antibodies during viral infections, which 
avoids the expensive and complex preparation and 
characterization of monoclonal antibodies. The use of 
mimetic peptides which are obtained from the phage 
display libraries selection as antigens in diagnostics has 
been suggested as an alternative for the use of gross 
viral antigens. Using such peptides may eliminate the 
high ratio of unsuitable epitopes present in the 
preparations of gross antigens, producing a more efficient 
and specific diagnosis (Casey et al., 2009). The use of 
mimetic peptides may also work as a positive control 
precisely defined and suitable for diagnostic tests, and as 
an alternative whenever the original antigen is hard to 
obtain, unstable, or in the case of a virus with erratic 
distribution (Ziegler et al., 1998). 
The mimetic peptides selected in this work can be 
potentially utilized as antigens in EBL diagnosis, develop-
ment of vaccines, and as a basis for the production of 
synthetic peptides. According to the results obtained, the 
synthetic peptide VLB-Ph has the potential for use as 
antigen in ELISA for the diagnosis of EBL. This study 
provided alternatives for the development of new 
methodologies for EBL diagnosis via the production of 
new antigens that may be used in routine and large scale 
procedures, contributing directly to the control and 
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